Kjellin Midori, Wesslén Terése, Löfblad Erik, Lennerstrand Johan, and Lannergård Anders. 2018. “The Effect of the First-Generation HCV-Protease Inhibitors Boceprevir and Telaprevir and the Relation to Baseline NS3 Resistance Mutations in Genotype 1: Experience from a Small Swedish Cohort”. Upsala Journal of Medical Sciences 123 (1):50–56. https://doi.org/10.1080/03009734.2018.1441928.